Our Team

Michael is a Director of Investments at LeapFrog, where he has been a key member of the global healthcare investment team since 2016. He leads deal execution and drives value-creation initiatives across LeapFrog’s healthcare portfolio, helping innovative businesses to scale and deliver impact across global growth markets.

Michael was instrumental in the firm’s 2020 investment in MedGenome, the leading genomic diagnostics provider in South Asia, where he currently serves on the board and supports the company’s ongoing global expansion. He also led the acquisition of Goodlife Pharmacies, which has grown into East Africa’s largest retail pharmacy chain under his team’s strategic direction.

Prior to joining LeapFrog, Michael was a private equity investor with RoundTable Healthcare Partners, where he evaluated new investment opportunities and worked extensively with portfolio company executives to streamline operations and improve profitability. Michael also spent time as a Principal with Open Capital Advisors, a management consulting and financial advisory firm supporting growth-stage businesses across Africa. He began his career in investment banking at Oppenheimer & Co. in New York, advising on mergers and acquisitions, leveraged buyouts, and financings across the healthcare industry.

Michael holds a Master in Public Administration from Harvard University’s Kennedy School of Government and a Bachelor of Business Administration from the University of Michigan’s Stephen M. Ross School of Business.